Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave Aurora, CO 80045

720-848-0000

Lia Gore, MD

Pediatric Hematology / Oncology

Board Certified

Locations

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045

720-777-1234

Get directions

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045

720-848-0000

Get directions

UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045

720-848-0000

Get directions

University of Colorado Cancer Center
CU Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045

720-848-0300

Get directions

Provider Expertise

Clinical Interest for Patients

I am interested in Phase 1 Clinical Trials with Special Emphasis on Acute Leukemias/Bone Marrow Transplant and Cell Therapies.


Care Philosophy

I believe that each patient and each family require an individual approach appropriate to the needs and situation being faced. I work hard to ensure that the best and most complete information is available and try to work toward solutions and plans that meet people at the level at which they are most comfortable. I believe in a team-based approach that brings the best minds and ideas together to find the best options available.


Specialties

  • Pediatric Hematology / Oncology ( 2001 , 2017 )
  • Pediatrics ( 1996 , 2003 )

Conditions & Treatments

  • Cancers

    Bone Cancer, Brain Cancer, Cancer Medicine, Chemotherapy, Leukemia (Adult Acute), Leukemia (Adult Chronic), Leukemia (Childhood), Lung Cancer, Lymphoma, Pediatric Cancer

  • Blood / Lymphatic System

    Blood Disorders

  • Brain and Nervous System

    Brain Tumors

Interests & Activities

Volunteer Activities

Roundup River Ranch: a SeriousFun Network Camp Carleton College


Education & Training

Medical Schools

MD, George Washington University School of Medicine and Health Sciences (1993)


Undergraduate Schools

BA, Carleton College (MN) (1987)


Internships

George Washington University/Children's National Medical Center Program (1994)


Residency Program

George Washington University/Children's National Medical Center Program (1994)

University of Colorado (Children's Hospital Colorado) Program (1996)


Fellowships

University of Colorado (Children's Hospital Colorado) Program (2001)

University of Colorado (Children's Hospital Colorado) Program (1999)

National Cancer Institute (2002)

Professional Memberships

American Association of Cancer Research, Full Member


American Society of Clinical Oncology, Full Member


American Society of Hematology, Full Member


American Society of Pediatric Hematology/Oncology, Member


Children’s Oncology Group, Member


University of Colorado Cancer Center, Member


Research & Grants

Grants

A single-arm multicenter phase II study preceded by Dose Evaluation to investigate the efficacy, safety, and tolerability of the BiTE antibody blinatumomab in pediatric and adolescent patients with Relapsed/Refractory B-ALL (2012)

Experimental Therapeutics Program at Children’s Hospital Colorado (2014)

Southwest Early Clinical Trials Consortium (UM1) (2014)

Post-graduate Training in Pediatric Oncology (2015)

Precision-based Therapy for Childhood Leukemia Consortium Grant (2016)

Impact Grant (2017)

Cancer Center Support Grant - Senior Leaders (2017)

Pediatric Cancer Immunotherapy Trials Network (2017)

Pediatric Early Phase Clinical Trials NetworkSub-award CFDA 93.395 “Agent Prioritization Committee” (2020)

Children's Oncology Group NCTN Network Group Operations Center (2020)


Research Interests for Patients

I am interested in Phase I clinical trials and Clinical-Translational Research in novel cancer treatments, with a particular emphasis on leukemias, sarcomas, and pediatric brain tumors.

information for referring providers

Referral Contact Phone

720-777-1234

Clinical Interests for Referring Providers

I am interested in Phase 1 Clinical Trials with Special Emphasis on Acute Leukemias/Bone Marrow Transplant-Cellular Therapies and new treatments for a variety of cancers.

Research Interest for Referring Providers

Phase I clinical trials and Clinical-Translational Research in novel cancer therapeutics and drug development for high risk pediatric cancers and for hematological malignancies.